Evofem Biosciences Inc

Change company Symbol lookup

Select an option...

EVFM Evofem Biosciences Inc

FCO Aberdeen Global Income Fund Inc.

DTEC ALPS Disruptive Technologies ETF

$RUIRETAILT Russell 1000 RGS Retail Total Return

BAC Bank of America Corp

MA Mastercard Inc

AAPL Apple Inc

AA Alcoa Corp

AMD Advanced Micro Devices Inc

PFE Pfizer Inc

Go

Evofem Biosciences Inc, formerly Neothetics, Inc., is a clinical-stage specialty biopharmaceutical company. The Company develops products to address unmet needs in women's sexual and reproductive health. The Company’s product Amphora, is a Multipurpose Vaginal pH Regulator (MVP-R) designed to regulate vaginal pH to within the normal range of 3.5 to 4.5 even in the presence of semen. This maintains an acidic environment which is inhospitable to sperm as well as certain viral and bacterial pathogens associated with sexually transmitted infections. Amphora is used to prevent urogenital chlamydia and gonorrhea in women. The Company is in the second Phase III clinical trial of Amphora for prevention of pregnancy (AMP002). The Company is currently designing a Phase IIb trial for its second product candidate, a MVP-R to reduce the recurrence of bacterial vaginosis.